ARTICLE | Company News
PaxVax sales and marketing update
November 3, 2016 10:43 PM UTC
PaxVax launched Vaxchora (PXVX0200) in the U.S. to prevent cholera caused by serogroup O1 in adults aged 18 to 64 traveling to cholera-affected areas. The live attenuated vaccine against Vibrio choler...
BCIQ Company Profiles